DR. JAMES M O'MARA M.D., PA
Prescription History 1093764607
Obstetrics & Gynecology in Trenton, NJ

Active since May 09, 2006PECOS EnrolledAccepts Medicare AssignmentCLIA 31D0692755 · Microscopy
1450 PARKSIDE AVE, SUITE #20, TRENTON, NJ 08638(609) 530-1818 Get Directions

NPPES record last updated: September 22, 2009. Verified against the NPPES registry weekly; last sync: October 11, 2026.

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. JAMES M O'MARA M.D., PA, an active Obstetrics & Gynecology specialist practicing in Trenton, NJ. Our medical registry currently tracks 2 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 35 documented patient claims. Among these therapy options, the most frequently utilized medication is Estradiol, which accounts for 20 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

2
Medications
35
Total Claims
100
30-Day Fills
Estradiol
Most Prescribed · 20 claims
View details
2 medications · 2024 Medicare Part D
Medicare Part D medications prescribed by DR. JAMES M O'MARA M.D., PA in 2024, with prescription volumes, average cost per fill, and NJ state comparisons
Medication Prescriptions (2024)Rx (2024) Avg Cost per FillCost / Fill Vs. Other NJ PrescribersVs. NJ Avg
Estradiol20$103.58▼ Less than typical

About Estradiol: This medication is a hormone. Show more ▾

It is used by women to help reduce vaginal symptoms of menopause (such as vaginal dryness/burning/itching). These symptoms are caused by the body making less estrogen. When treating only vaginal symptoms of menopause, products applied directly inside the vagina (such as this medication) should be used first. Estrogens that are taken by mouth, absorbed through the skin, or injected may have greater risks of side effects due to more estrogen being absorbed. The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids.

In 2024, this provider wrote 20 Medicare prescriptions for Estradiol, about half the volume of the typical New Jersey prescriber of this medication (45.3). Medicare paid an average of $103.58 per fill, versus $77.45 statewide.

How often this provider prescribes it

This provider
20
NJ average
45.3

This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$103.58
NJ average
$77.45

Gross Part D cost per fill; not the patient's out-of-pocket price.

55.5
30-Day Fills
standardized to 30-day supplies
1,666
Days of Medication
total across all patients in 2024
Medroxyprogesterone Acetate15$20.44▼ below NJ avg≈ Typical

About Medroxyprogesterone Acetate: Medroxyprogesterone is a type of hormone (progestin). Show more ▾

This medication is similar to the progesterone that your body naturally makes and is given to replace the hormone when your body is not making enough of it. This medication has several uses. In women who are not pregnant and not going through menopause, this medication is used to treat abnormal bleeding from the uterus and to restore normal menstrual periods in women who have stopped having them for several months (amenorrhea). Medroxyprogesterone is also used as part of combination hormone replacement therapy with estrogens to reduce menopause symptoms (such as hot flashes). Medroxyprogesterone is added to estrogen replacement therapy to reduce the risk of cancer of the uterus. Some brands of this medication may also be used to treat certain types of cancers (breast cancer, endometrial cancer). This medication must not be used to test for pregnancy. A synthetic progestin that is derived from 17-hydroxyprogesterone. It is a long-acting contraceptive that is effective both orally or by intramuscular injection and has also been used to treat breast and endometrial neoplasms.

In 2024, this provider wrote 15 Medicare prescriptions for Medroxyprogesterone Acetate, about 88% of the volume of the typical New Jersey prescriber of this medication (17). Medicare paid an average of $20.44 per fill, versus $24.82 statewide.

How often this provider prescribes it

This provider
15
NJ average
17.0

This provider's prescribing volume for this medication is in line with the average NJ prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$20.44
NJ average
$24.82

This provider's average cost per fill is below the NJ average for this medication.

44.4
30-Day Fills
standardized to 30-day supplies
1,332
Days of Medication
total across all patients in 2024
No medications match the current filters.
▲ More than typical≈ Typical▼ Less than typical= prescription volume vs the average NJ prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the NJ average cost per fill.

About this data. The prescription history for DR. JAMES M O'MARA M.D., PA is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Obstetrics & Gynecology prescribing approach at this Trenton, NJ practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among NJ prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.

About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.